We are currently supported by:Fellowship
"RNP complexes in health and disease and their therapeutic targeting" (2022-2026)
- Motor Neurone Disease Association
Senior Non-Clinical Fellowship (converted into a research grant):
“Long non-coding RNA NEAT1 in motor neurone physiology and pathophysiology” (2018-2023)
PhD studentship:
"NEAT1 isoforms in the regulation of cellular glucose metabolism downstream TDP-43 dysfunction in ALS" (2023-2027)
Research grant: "Mechanistic studies of ALS-causative mutations and RNP-focussed drug discovery using in vitro reconstitution of RNP complexes" (2022-2025)
PhD Studentship: "Small molecule modulators of stathmin-2 splicing as a novel ALS therapy"(2022-2025)
Research grant: “Understanding the crosstalk between spatially separated RNP granules during cellular stress responses” (2022-2024)
- MRC/AZ Centre for Lead Discovery award for the identification of small molecules modulators of NEAT1_2/paraspeckles (co-I, with Cardiff)
Previous funding:
- Medical Research Foundation
MRF fellowship: “Dissecting the role of the paraspeckle in amyotrophic lateral sclerosis” (2015-2018)
- Academy of Medical Sciences
AMS Springboard Award: “Developing tools to monitor expression of lncRNA NEAT1 isoforms for basic research and drug discovery” (2019-2021)
ISSF Translational Kickstart Award “Identification of chemotypes selectively binding to a structured motif of lncRNA NEAT1 as templates for novel drugs” (2019-2021)
Sêr Cymru III – Tackling COVID-19 grant (2020-2021)